Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 886 AL 900

Patients with scans without evidence of dopaminergic deficit (SWEDD) do not have early Parkinson's disease: Analysis of the PPMI data

Lee JW, Song YS, Kim H, Ku BD, Lee WW.

PLoS One. 2021 Feb 10;16(2):e0246881. doi: 10.1371/journal.pone.0246881. eCollection 2021.

Tau in the gut, does it really matter?

Derkinderen P, Rolli-Derkinderen M, Chapelet G, Neunlist M, Noble W.

J Neurochem. 2021 Jul;158(2):94-104. doi: 10.1111/jnc.15320. Epub 2021 Feb 24.

Neuropeptides: Roles and Activities as Metal Chelators in Neurodegenerative Diseases

Ben-Shushan S, Miller Y.

J Phys Chem B. 2021 Mar 25;125(11):2796-2811. doi: 10.1021/acs.jpcb.0c11151. Epub 2021 Feb 11.

Hidden phenotypes of PINK1/Parkin knockout mice

Paul S, Pickrell AM.

Biochim Biophys Acta Gen Subj. 2021 Jun;1865(6):129871. doi: 10.1016/j.bbagen.2021.129871. Epub 2021 Feb 9.

The pleiotropic neuroprotective effects of resveratrol in cognitive decline and Alzheimer's disease pathology: From antioxidant to epigenetic therapy

Griñán-Ferré C, Bellver-Sanchis A, Izquierdo V, Corpas R, Roig-Soriano J, Chillón M, Andres-Lacueva C, Somogyvári M, Sőti C, Sanfeliu C, Pallàs M.

Ageing Res Rev. 2021 May;67:101271. doi: 10.1016/j.arr.2021.101271. Epub 2021 Feb 8.

Compound heterozygous variants in Wiskott-Aldrich syndrome like (WASL) gene segregating in a family with early onset Parkinson's disease

Kumar S, Abbas MM, Govindappa ST, Muthane UB, Behari M, Pandey S, Juyal RC, Thelma BK.

Parkinsonism Relat Disord. 2021 Mar;84:61-67. doi: 10.1016/j.parkreldis.2021.02.001. Epub 2021 Feb 5.

Allosteric Interactions between Adenosine A(2A) and Dopamine D(2) Receptors in Heteromeric Complexes: Biochemical and Pharmacological Characteristics, and Opportunities for PET Imaging

Prasad K, de Vries EFJ, Elsinga PH, Dierckx RAJO, van Waarde A.

Int J Mol Sci. 2021 Feb 9;22(4):1719. doi: 10.3390/ijms22041719.

Curcumin as Scaffold for Drug Discovery against Neurodegenerative Diseases

Lo Cascio F, Marzullo P, Kayed R, Palumbo Piccionello A.

Biomedicines. 2021 Feb 9;9(2):173. doi: 10.3390/biomedicines9020173.

Interaction between Parkin and α-Synuclein in PARK2-Mediated Parkinson's Disease

Madsen DA, Schmidt SI, Blaabjerg M, Meyer M.

Cells. 2021 Jan 31;10(2):283. doi: 10.3390/cells10020283.

Gastrointestinal Dysfunction in Parkinson's Disease

Skjærbæk C, Knudsen K, Horsager J, Borghammer P.

J Clin Med. 2021 Jan 31;10(3):493. doi: 10.3390/jcm10030493.

Systematic Review of Nicotine Exposure's Effects on Neural Stem and Progenitor Cells

Brooks AC, Henderson BJ.

Brain Sci. 2021 Jan 29;11(2):172. doi: 10.3390/brainsci11020172.

Think Big, Start Small: How Nanomedicine Could Alleviate the Burden of Rare CNS Diseases

Faouzi A, Roullin VG.

Pharmaceuticals (Basel). 2021 Jan 30;14(2):109. doi: 10.3390/ph14020109.

Bile Acids and Microbiota: Multifaceted and Versatile Regulators of the Liver-Gut Axis

Grüner N, Mattner J.

Int J Mol Sci. 2021 Jan 30;22(3):1397. doi: 10.3390/ijms22031397.

Two-step treatment of a giant skull vault hemangioma: A rare case report and literature review

Anagnostou E, Lagos P, Plakas S, Mitsos A, Samelis A.

Neurocirugia (Engl Ed). 2021 Feb 8:S1130-1473(21)00007-5. doi: 10.1016/j.neucir.2020.12.005. Online ahead of print.

Targeting the Mitochondrial Permeability Transition Pore to Prevent Age-Associated Cell Damage and Neurodegeneration

Kent AC, El Baradie KBY, Hamrick MW.

Oxid Med Cell Longev. 2021 Jan 28;2021:6626484. doi: 10.1155/2021/6626484. eCollection 2021.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias